ASTERIAS BIOTHERAPEUTICS INC
Menlo Park, California, 94025, United States, 11-50 Employees
Phone Number: +15*********
Who is ASTERIAS BIOTHERAPEUTICS INC
Asterias Biotherapeutics is a leading biotechnology company in the emerging field of regenerative medicine. The company’s proprietary cell therapy programs are based on its immunotherapy ...
Read More
-
Headquarters: Menlo Park, California, 94025, United States
-
Employees: 11-50
-
Revenue: 5 Million to 10 Million
-
CEO: Michael Mulroy
SIC Code: 2834
|
NAICS Code: 325412 |
Show More
Does something look wrong? Fix it. | View contact records from ASTERIAS BIOTHERAPEUTICS INC
View Employees
Asterias Biotherapeutics Inc Org Chart and Mapping
Similar Companies to Asterias Biotherapeutics Inc
Advantec Co.
-
11-50
-
$ 5 Million to 10 Million
Alera Labs, Llc
-
11-50
-
$ 5 Million to 10 Million
Alios Biopharma
-
11-50
-
$ 5 Million to 10 Million
Asterias Biotherapeutics Inc Activity Score
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Asterias Biotherapeutics Inc
Answer: Asterias Biotherapeutics Inc's headquarters are located at Menlo Park, California, 94025, United States
Answer: Asterias Biotherapeutics Inc's phone number is +15*********
Answer: Asterias Biotherapeutics Inc's official website is https://asteriasbio.com
Answer: Asterias Biotherapeutics Inc's revenue is 5 Million to 10 Million
Answer: Asterias Biotherapeutics Inc's SIC: 2834
Answer: Asterias Biotherapeutics Inc's NAICS: 325412
Answer: Asterias Biotherapeutics Inc has 11-50 employees
Answer: Asterias Biotherapeutics Inc top competitors include: Reuzeit, Biosentinel, Inc., Orum Therapeutics, Thrive Bioscience, Inc., Alera Labs, Llc, Elevation Oncology, Bioaccel, Quantem Laboratories, Microbix, Alios Biopharma, Advantec Co.
Answer: Asterias Biotherapeutics Inc contact info: Phone number: +15********* Website: https://asteriasbio.com
Answer: Asterias Biotherapeutics is a leading biotechnology company in the emerging field of regenerative medicine. The company’s proprietary cell therapy programs are based on its immunotherapy and pluripotent stem cell platform technologies. Asterias is presently focused on advancing three clinical-stage programs which have the potential to address areas of very high unmet medical need in the fields of oncology and neurology.
Answer:
Premium Sales Data for Prospecting
- Sales data across over 200M records
- Up-to-date records (less decayed data)
- Accurate Email Lists (real-world tested)
- Powerful search engine and intuitive interface
CEO at Asterias Biotherapeutics Inc
View Employees
Asterias Biotherapeutics Inc Activity Score
Sign in to CIENCE GO Data to uncover contact details
Free credits every month